Stock BIOSTEM TECHNOLOGIES INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Biostem Technologies Inc

Equities

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Biostem Technologies Inc
05-14 Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M MT
2023 NovaBay to Commercialize BioStem's Amniotic Tissue Allograft MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M
MT
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
AQ
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
AQ
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
AQ
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts
AQ
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase
AQ
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
AQ
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference
AQ
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
AQ
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
AQ
PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market
AQ
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
AQ
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
AQ
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
AQ
Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions
AQ
BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors
AQ
BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results
AQ
BioStem Technologies Awarded Q Code for VENDAJE AC® Line from Centers for Medicare and Medicaid Services
AQ
BioStem Technologies Closes Oversubscribed $2M Private Placement
AQ
BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Biostem Technologies Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW